CDLX - Company ID 0001666071
The table below shows Cardlytics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $34.32M | $52.03M | $63.25M | $56.44M | $67.06M | $69.64M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $6.43M | $8.80M | $11.29M | $10.28M | $13.19M | $13.47M |
Cardlytics, Inc. reported annual revenue of $233.27M for fiscal year 2025. That is down 16.2% from $278.30M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $112.82M (FY 2016) to $233.27M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $8.28M |
| $10.85M |
| $12.90M |
| $12.94M |
| $12.08M |
| $16.15M |
| Operating income | -$8.27M | -$68.85M | -$12.79M | -$11.12M | -$148.55M | -$15.81M |
| Income tax | $0.00 | - | - | $0.00 | - | - |
| Net income | -$4.48M | -$72.67M | -$9.28M | -$13.28M | -$145.18M | -$4.26M |
| EPS (diluted) | - | -$1.36 | -$0.18 | -$0.26 | -$2.90 | -$0.09 |